CRP and neoplasm: In this case, the patient’s serum CRP level significantly reduced from 36 mg/L to 2.69 mg/L since Camrelizumab and RT for L5 metastasis intervention, as well as CN afterwards, which may reflect the combination therapy of ICI and RT does reduce the tumor burden.